Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

E2A Inhibitors

E2A inhibitors encompass a distinct group of organic compounds that exert their effects through selective modulation of E2A transcription factors, which are pivotal components in cellular processes. These inhibitors are meticulously engineered molecules designed to interact with specific binding sites on E2A transcription factors, leading to alterations in their functional conformation and subsequent interference with their DNA binding capabilities. This intricate mechanism of action results in the modulation of downstream gene expression patterns, influencing a range of cellular functions such as differentiation, proliferation, and survival. E2A inhibitors exhibit a finely tuned chemical structure that ensures precise and potent interaction with the target transcription factors. This involves the careful design of molecular features that enable optimal binding affinity and selectivity, contributing to the specificity of their mode of action. By disrupting the normal protein-DNA interactions within the E2A transcription factors, these inhibitors serve as valuable tools for researchers aiming to decipher the intricacies of gene regulation networks. The study of E2A inhibitors expands our understanding of fundamental cellular processes and offers insights into avenues for further exploration in diverse scientific contexts. The ongoing research into E2A inhibitors continues to unveil their roles in shaping cellular behavior, further unraveling the complexities of gene regulation. Through their ability to modulate E2A transcription factors, these compounds provide a unique means to probe into the molecular underpinnings of various physiological responses, presenting opportunities for advancements in multiple scientific disciplines. As investigations into E2A inhibitors progress, their diverse applications and implications within the realm of cellular and molecular biology come to the forefront, contributing to the ongoing expansion of our knowledge in this intricate field.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CAL-101

870281-82-6sc-364453
10 mg
$193.00
4
(1)

CAL-101 is a selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor used in cancer therapy. It interferes with the PI3Kδ pathway, inhibiting cell proliferation and promoting apoptosis.

Syk Inhibitor IV, BAY 61-3606 HCl

732983-37-8sc-202351
2 mg
$327.00
25
(1)

BAY 61-3606 is a Syk (spleen tyrosine kinase) inhibitor that may indirectly impact E2A function by affecting downstream signaling pathways.

ABT 263

923564-51-6sc-207241
5 mg
$245.00
16
(1)

ABT 263 inhibits Bcl-2 family proteins, leading to disruption of mitochondrial pathways and apoptosis. It indirectly affects E2A function in B cell survival.

Acalabrutinib

1420477-60-6sc-507392
250 mg
$255.00
(0)

Acalabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor that can affect B cell receptor signaling and indirectly influence E2A-mediated transcription.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Ibrutinib covalently binds to BTK and inhibits its activity, leading to decreased B cell receptor signaling and potential effects on E2A-driven processes.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Dasatinib is a multi-kinase inhibitor that targets Src family kinases and BCR-ABL, impacting B cell receptor signaling and potentially E2A-associated functions.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Lenalidomide modulates the immune system and affects cytokine signaling, potentially influencing E2A-driven processes in immune cell differentiation.

Tirabrutinib

1351636-18-4sc-507435
10 mg
$138.00
(0)

ONO-4059 is a BTK inhibitor that can disrupt B cell receptor signaling, influencing downstream events involving E2A-mediated transcription.

IPI 145

1201438-56-3sc-488318
5 mg
$317.00
(0)

Duvelisib inhibits both PI3Kδ and PI3Kγ, potentially impacting B cell signaling pathways and E2A-associated processes.

TG101348

936091-26-8sc-364740
sc-364740A
5 mg
25 mg
$207.00
$515.00
6
(1)

TG101348 inhibits JAK2 and other JAK family members, potentially affecting cytokine signaling and E2A-related functions in hematopoiesis.